ANI Pharmaceuticals to Participate at Leerink Partners Therapeutics Forum: I&I and Metabolism on July 8th
ANI Pharmaceuticals (NASDAQ:ANIP) announced its participation in the upcoming Leerink Partners Therapeutics Forum, focusing on I&I and Metabolism. The company's President and CEO, Nikhil Lalwani, will be conducting one-on-one meetings with investors during the event, which takes place on July 8, 2025, in Boston, MA.
ANI Pharmaceuticals (NASDAQ:ANIP) ha annunciato la sua partecipazione al prossimo Leerink Partners Therapeutics Forum, incentrato su I&I e Metabolismo. Il Presidente e CEO dell'azienda, Nikhil Lalwani, terrà incontri individuali con gli investitori durante l'evento, che si svolgerà il 8 luglio 2025 a Boston, MA.
ANI Pharmaceuticals (NASDAQ:ANIP) anunció su participación en el próximo Leerink Partners Therapeutics Forum, enfocado en I&I y Metabolismo. El Presidente y CEO de la compañía, Nikhil Lalwani, realizará reuniones individuales con inversores durante el evento, que tendrá lugar el 8 de julio de 2025 en Boston, MA.
ANI Pharmaceuticals (NASDAQ:ANIP)는 I&I 및 대사에 중점을 둔 다가오는 Leerink Partners Therapeutics Forum에 참여한다고 발표했습니다. 회사의 사장 겸 CEO인 Nikhil Lalwani가 2025년 7월 8일 보스턴, MA에서 열리는 행사 기간 동안 투자자들과 일대일 미팅을 진행할 예정입니다.
ANI Pharmaceuticals (NASDAQ:ANIP) a annoncé sa participation au prochain Leerink Partners Therapeutics Forum, axé sur l'I&I et le métabolisme. Le président et CEO de la société, Nikhil Lalwani, tiendra des réunions individuelles avec des investisseurs lors de l'événement qui se déroulera le 8 juillet 2025 à Boston, MA.
ANI Pharmaceuticals (NASDAQ:ANIP) gab seine Teilnahme am bevorstehenden Leerink Partners Therapeutics Forum bekannt, das sich auf I&I und Stoffwechsel konzentriert. Der Präsident und CEO des Unternehmens, Nikhil Lalwani, wird während der Veranstaltung am 8. Juli 2025 in Boston, MA, Einzelgespräche mit Investoren führen.
- None.
- None.
PRINCETON, N.J., July 02, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced that Nikhil Lalwani, President and Chief Executive Officer, will host 1x1 meetings at the Leerink Partners Therapeutics Forum: I&I and Metabolism on Tuesday, July 8, 2025, in Boston, MA.
About ANI Pharmaceuticals, Inc.
ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) is a diversified biopharmaceutical company committed to its mission of “Serving Patients, Improving Lives" by developing, manufacturing, and commercializing innovative and high-quality therapeutics. The Company is focused on delivering sustainable growth through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; its Generics business, which leverages R&D expertise, operational excellence, and U.S.-based manufacturing; and its Brands business. For more information, visit www.anipharmaceuticals.com.
Investor Relations:
Lisa M. Wilson, In-Site Communications, Inc.
T: 212-452-2793
E: lwilson@insitecony.com
Source: ANI Pharmaceuticals, Inc.
FAQ
When is ANI Pharmaceuticals (ANIP) participating in the Leerink Partners Therapeutics Forum?
Who will represent ANI Pharmaceuticals at the Leerink Partners Forum?
What type of meetings will ANI Pharmaceuticals conduct at the Leerink Partners Forum?
What is the focus of the Leerink Partners Therapeutics Forum where ANIP will participate?
